Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Cash Flow Reinvestment Rate
Latest as of September 2025:
0.00x
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $4.00 (capex $4.00 ) from operating cash flow of $137.91K. Check Drugs Made In America Acquisition Corp. (DMAA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$4.00
Capex + Investments
Operating Cash Flow
$137.91K
USD
Capital Expenditures
$4.00
USD
Annual Cash Flow Reinvestment Rate for Drugs Made In America Acquisition Corp. Ordinary Shares (None–None)
Year-by-year capital reinvestment analysis for Drugs Made In America Acquisition Corp. Ordinary Shares. For live market cap and broader valuation context, see Drugs Made In America Acquisition Corp. (DMAA) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow